4//SEC Filing
MORNEAU MICHAEL 4
Accession 0001209191-18-004973
CIK 0001607678other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:42 PM ET
Size
7.6 KB
Accession
0001209191-18-004973
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.00001 per share
2018-01-19+15,000→ 101,651 total - Award
Stock Option (Right to Buy)
2018-01-19+52,500→ 52,500 totalExercise: $4.65From: 2019-01-19Exp: 2028-01-19→ Common Stock (52,500 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award.
- [F2]Includes 3,004 shares acquired on May 19, 2017 pursuant to the Issuer's 2014 Employee Stock Purchase Plan and 3,043 shares acquired on November 20, 2017 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.
- [F3]25% of the shares subject to the option will vest on each anniversary of the grant date.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001517780
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:42 PM ET
- Size
- 7.6 KB